John L. Leguyader

Array ( [id] => 4043435 [patent_doc_number] => 05874414 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Trans-splicing ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/090192 [patent_app_country] => US [patent_app_date] => 1993-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 25 [patent_no_of_words] => 13072 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874414.pdf [firstpage_image] =>[orig_patent_app_number] => 090192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3526556 [patent_doc_number] => 05527895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-18 [patent_title] => 'HIV targeted hairpin ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/153367 [patent_app_country] => US [patent_app_date] => 1993-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 89 [patent_no_of_words] => 32886 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/527/05527895.pdf [firstpage_image] =>[orig_patent_app_number] => 153367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3529155 [patent_doc_number] => 05583039 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Escherichia coli containing a gene encoding a maltogenic amylase BLMA of Bacillus licheniformis and gene product produced by same' [patent_app_type] => 1 [patent_app_number] => 8/152271 [patent_app_country] => US [patent_app_date] => 1993-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 5916 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/583/05583039.pdf [firstpage_image] =>[orig_patent_app_number] => 152271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3101665 [patent_doc_number] => 05447857 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-05 [patent_title] => 'Process for producing L-tryptophan' [patent_app_type] => 1 [patent_app_number] => 8/147541 [patent_app_country] => US [patent_app_date] => 1993-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8589 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/447/05447857.pdf [firstpage_image] =>[orig_patent_app_number] => 147541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3475729 [patent_doc_number] => 05432081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-11 [patent_title] => 'Host cells transformed with the E. coli glucoronide permease gene' [patent_app_type] => 1 [patent_app_number] => 8/138546 [patent_app_country] => US [patent_app_date] => 1993-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 29 [patent_no_of_words] => 33922 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/432/05432081.pdf [firstpage_image] =>[orig_patent_app_number] => 138546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3698013 [patent_doc_number] => 05596090 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Antisense oligonucleotides directed against human VCAM-1 RNA' [patent_app_type] => 1 [patent_app_number] => 8/137701 [patent_app_country] => US [patent_app_date] => 1993-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11180 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/596/05596090.pdf [firstpage_image] =>[orig_patent_app_number] => 137701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646811 [patent_doc_number] => 05683909 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Plasmids replicatable in Bacillus subtilis, E. coli and lactic acid streptococcus bacteria' [patent_app_type] => 1 [patent_app_number] => 8/135133 [patent_app_country] => US [patent_app_date] => 1993-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 11427 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/683/05683909.pdf [firstpage_image] =>[orig_patent_app_number] => 135133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3518731 [patent_doc_number] => 05529932 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-25 [patent_title] => 'Isolated DNA encoding a plant ribosome inactivating protein from the leaves of saponaria officinalis' [patent_app_type] => 1 [patent_app_number] => 8/133278 [patent_app_country] => US [patent_app_date] => 1993-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4189 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/529/05529932.pdf [firstpage_image] =>[orig_patent_app_number] => 133278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3576461 [patent_doc_number] => 05523389 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-04 [patent_title] => 'Inhibitors of human immunodeficiency virus' [patent_app_type] => 1 [patent_app_number] => 8/128011 [patent_app_country] => US [patent_app_date] => 1993-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 8482 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/523/05523389.pdf [firstpage_image] =>[orig_patent_app_number] => 128011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3423998 [patent_doc_number] => 05422249 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-06 [patent_title] => 'Process for the manufacture of thrombin inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/121974 [patent_app_country] => US [patent_app_date] => 1993-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 29236 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/422/05422249.pdf [firstpage_image] =>[orig_patent_app_number] => 121974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3429541 [patent_doc_number] => 05463024 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-31 [patent_title] => 'Fusion proteins and particles' [patent_app_type] => 1 [patent_app_number] => 8/115397 [patent_app_country] => US [patent_app_date] => 1993-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 29 [patent_no_of_words] => 7906 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/463/05463024.pdf [firstpage_image] =>[orig_patent_app_number] => 115397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3125695 [patent_doc_number] => 05436330 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-25 [patent_title] => 'Hammerhead ribozymes with enhanced stability provided by an additional 3\' h a' [patent_app_type] => 1 [patent_app_number] => 8/111444 [patent_app_country] => US [patent_app_date] => 1993-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3386 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/436/05436330.pdf [firstpage_image] =>[orig_patent_app_number] => 111444 [rel_patent_id] =>[rel_patent_doc_number] =>)